Gilead to Acquire Arcellx for Up to $7.8 Billion, Doubling Down on Next-Generation CAR-T Therapy Feb 24, 2026 Life Science
Aiming at a Billion-Dollar Market, Pfizer Doubles Down on Obesity Therapies in China Feb 24, 2026 Life Science
Novo Nordisk Shares Plunge 16% as CagriSema Lags Behind Lilly’s Drug in Key Trial Feb 23, 2026 Life Science
Forget AI and Weight-Loss Drugs: Why Vertex Pharmaceuticals Is the Silent Compounder You Need Feb 22, 2026 Life Science
Is the Current US Stock Market Lacking Bargains? These Two High-Yield Dividend Stocks Are Worth Watching Feb 19, 2026 Energy, Life Science
Searching for the Next ‘Star Stock’? Wall Street Recommends These Two Biotech Stocks Feb 19, 2026 Life Science
Can Viking Therapeutics Really Soar 300%? Why Wall Street Is Betting Big on This Biotech Stock Feb 19, 2026 Life Science
ImmunityBio Soars Over 40% as European Commission Approves Bladder Cancer Drug Anktiva Feb 18, 2026 Life Science
A Once-in-a-Decade Buying Opportunity Emerges! Three Stocks Not to Be Missed Feb 18, 2026 Life Science
Why Alnylam Soared 6%: One Analyst Says the Biotech’s Growth Story Is Just Getting Started Feb 17, 2026 Life Science
CRISPR Therapeutics Soars as Partner Vertex Drops Optimistic 2026 Sales Guidance Feb 13, 2026 Life Science
AI Empowers New Drug Development at the Right Time: These Two Biotech Stocks Are Not to Be Missed Feb 12, 2026 Life Science
